Physics Contribution
Combined Photon and Electron Three-Dimensional Conformal Versus Intensity-Modulated Radiotherapy With Integrated Boost for Adjuvant Treatment of Malignant Pleural Mesothelioma After Pleuropneumonectomy

https://doi.org/10.1016/j.ijrobp.2007.07.2370Get rights and content

Purpose

The optimal technique for postoperative radiotherapy (RT) after extrapleural pleuropneumonectomy (EPP) of malignant pleural mesothelioma (MPM) remains debated.

Methods and Materials

The data from 8 right-sided and 9 left-sided consecutive cases of MPM treated with RT after radical EPP were reviewed. Of the 17 patients, 8 had been treated with three-dimensional (3D) conformal RT (3D-CRT) and 9 with intensity-modulated RT (IMRT) with 6-MV photons. The clinical outcome and adverse events were assessed. For comparative planning, each case was replanned with 3D-CRT using photons and electrons or with IMRT. Homogeneity, doses to the organs at risk, and target volume coverage were analyzed.

Results

Both techniques yielded acceptable plans. The dose coverage and homogeneity of IMRT increased by 7.7% for the first planning target volume and 9.7% for the second planning target volume, ensuring ≥95% of the prescribed dose compared with 3D-CRT (p < 0.01). Compared with 3D-CRT, IMRT increased the dose to the contralateral lung, with an increase in the mean lung dose of 7.8 Gy and an increase in the volume receiving 13 Gy and 20 Gy by 20.5% and 7.2%, respectively (p < 0.01). A negligible dose increase to the contralateral kidney and liver was observed. No differences were seen for the spinal cord and ipsilateral kidney. Two adverse events of clinical relevant lung toxicity were observed with IMRT.

Conclusion

Intensity-modulated RT and 3D-CRT are both suitable for adjuvant RT. IMRT improves the planning target volume coverage but delivered greater doses to the organs at risk. Rigid dose constraints for the lung should be respected.

Introduction

The role of radiotherapy (RT) for palliative treatment of malignant pleural mesothelioma (MPM) is well established 1, 2. RT is effective for pain control in the case of thoracic wall invasion and is used for the prevention of malignant seeding after invasive procedures 3, 4. The role of RT within the setting of radical multimodal therapy is less well defined, although the thoracic relapse rates after extrapleural pleuropneumonectomy (EPP) of MPM are high and adjuvant treatment is warranted. In recent years, adjuvant RT has been advocated as a part of postoperative therapy, and various techniques with different field geometries and dose schedules have been used 5, 6. More recently, neoadjuvant therapy with preoperative chemotherapy has been added to the treatment concept and has shown promising results in specialized institutions (7).

The best-documented multimodal potentially curative approach to MPM is pleuropneumonectomy, combined with chemotherapy and RT (trimodality approach) in selected patients with early disease stages. The survival rate of a large series of 176 patients after surgery was 38% at 2 years and 15% at 5 years, with a median survival of 19 months (5). More recently, preoperative chemotherapy followed by EPP has been investigated, and its feasibility has been reported in a multicenter trial 7, 8. The benefit of preoperative chemotherapy, however, will remain difficult to prove unless randomized trials are initiated. In some cases, operable disease might progress during chemotherapy, rendering subsequent resection more difficult. In our experience, the overall treatment time resulting from combined chemotherapy followed by surgery and the protracted therapy-associated stress on patients have made postoperative RT potentially more difficult and more challenging (9). The radiation oncologist has to decide whether full coverage of the hemithorax can be proposed or a treatment volume limited to the initial tumor region is sufficient and feasible after chemotherapy and EPP in each case. There is little doubt that preoperative chemotherapy can jeopardize the benefits from RT because of cumulative toxicity and treatment-related asthenia. Furthermore, no standard for either chemotherapy or RT exists. In particular, the acceptable size of the target volumes, dose constraints, and radiation techniques should be considered before implementation of RT in multimodal settings.

We evaluated two RT techniques that were used in our center for the purpose of RT after chemotherapy and surgery for MPM: three-dimensional (3D) conformal RT (3D-CRT), used until 2004, and intensity-modulated RT (IMRT). With both planning techniques, the entire ipsilateral hemithorax was defined as the clinical target volume (CTV2), with a high-risk area represented by the macroscopically resected tumor (CTV1).

Section snippets

Methods and Materials

For this retrospective treatment planning study, we reviewed the clinical records of all patients (n = 17) diagnosed with MPM between 2000 and 2006 who were treated with chemotherapy followed by EPP and RT. All patients had presented with Stage cT1-T3N0-N1M0. Mediastinal staging was done using computed tomography (CT) and positron emission tomography/CT. Mediastinoscopy was performed in all patients to exclude mediastinal involvement; patients with mediastinal involvement did not qualify for

Results

The percentage of the PTVs receiving <95% and the percentage receiving >105% of the prescribed dose were assessed for 3D-CRT and IMRT. The mean dose for all structures was assessed. The percentage of the kidney (or heart) receiving >15 Gy (or 45 Gy), the percentage of the lung receiving >13 and 20 Gy, and the maximal dose to the spinal cord were evaluated (Table 2). The reported values were averaged for the 17 MPM patients from the present study. Dose delivery to the PTV was improved using

Discussion

Continuously improving technology have led to improved dose conformity and increasing interest in integrating RT in the treatment concepts of MPM 13, 14. Because IMRT is an optimal technical approach for treating concave regions with many critical and radiation-sensitive tissue structures in close proximity to the targeted region, it seems especially well suited for the treatment of MPM, especially because greater conformity has the potential to improve the effect of RT (15). However, more

Conclusion

Both 3D-CRT and IMRT might be adequate techniques for the treatment of MPM. In the present study, 3D-CRT and IMRT were both able to keep the maximal and mean doses in the OARs to less than the reported critical levels. However, after preoperative chemotherapy and EPP, the dose constraints must be reduced to respect the specific case. An individualized use of techniques respecting patient- and disease-specific features is the key for optimal use of RT. Still, IMRT seems to be the superior

References (21)

There are more references available in the full text version of this article.

Cited by (0)

Supported by the Radium Fund, University of Zurich, Switzerland to I. F. Ciernik.

Conflict of interest: none.

View full text